Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
about
Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screeningMRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice?Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningCancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screeningBreast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.An Assessment of Family History Information Captured in an Electronic Health RecordRapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic statusPatterns of breast magnetic resonance imaging use in community practiceThe 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now?The impact of patient age on breast cancer risk prediction models.Overutilization of Breast Cancer Screening in the US: Awareness of a Growing Problem.Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology AssessmentBreast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme
P2860
Q26770123-B11F9844-E7FA-4560-8FDB-20522BC71D67Q26785571-73BAEA6D-21DA-470B-A2E6-985636995E7DQ26801072-3E756179-2D2C-47ED-9371-8531BBE44995Q27001043-8E8E22DA-BBC4-4D5A-97DD-1412081797F3Q27025805-04626C78-95B5-495F-92A0-7DC7A1706D76Q27347760-7DC2D7E2-4363-4105-B8E5-4801766DA507Q28603814-49864BF7-E558-4ACD-8EBD-269878840150Q34094242-26B43217-7702-4AE7-8F2A-73D49FBC1863Q36547262-B9E91824-6A11-46BA-8CC2-324E5734B3A7Q37529123-D41914E8-87C7-4E54-8A21-B025535792DFQ38154495-F42FD5F4-5C25-41C5-AA6B-155CA0A24C99Q48280660-50188497-D04C-4943-89D8-29FB786ADA67Q49630333-6209EC01-0A85-4412-99C8-042D097CD7E6Q57119180-2EFCE01E-5490-4DC3-A482-4A2351AC1D45Q57266500-4D72A43C-6DEB-4092-BF7E-B6BF7013794A
P2860
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@en
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@nl
type
label
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@en
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@nl
prefLabel
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@en
Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
@nl
P2093
P1476
Which risk model to use? Clinical implications of the ACS MRI screening guidelines
@en
P2093
Alan Semine
Brian Drohan
Caroline Block
Claire Cronin
Elissa M Ozanne
Frederick Millham
Michael Jellinek
Phil Bosinoff
Taryn Rourke
P304
P356
10.1158/1055-9965.EPI-12-0570
P577
2012-10-23T00:00:00Z